Radiobiological Considerations in the Use of Total-Body Irradiation for Bone-Marrow Transplantation
- 1 April 1979
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 131 (1) , 243-247
- https://doi.org/10.1148/131.1.243
Abstract
On radiobiological grounds, a therapeutic [human leukemia] advantage should result when total body irradiation (TBl) in preparation for bone-marrow engraftment is given as a fractionated course rather than as a single exposure at logistically reasonable dose rates. This is because cells of hemopoietic origin in general show less capacity for repair of sublethal radiation injury than do cells of other organs Dose-limiting lung tolerance, in the context of fractionated TBl, is estimated to be at least 12 Gy [gray] (without correction) in increments of 2 Gy regardless of dose rate. A practical method for delivering TBl using a high energy linear accelerator is described.This publication has 5 references indexed in Scilit:
- Total-Body Irradiation with a High-Dose-Rate Linear Accelerator for Bone-Marrow Transplantation in Aplastic Anemia and Neoplastic DiseaseRadiology, 1977
- The incidence of radiation pneumonitis as a result of single fraction upper half body irradiationCancer, 1976
- Bone Marrow Transplantation in ManAnnals of Internal Medicine, 1975
- A Method for Investigation of Stern‐Cell KineticsBritish Journal of Haematology, 1962
- Radiosensitivity of Spleen Cells from Normal and Preimmunized Mice and Its Significance to Intact AnimalsThe Journal of Immunology, 1962